Schedule 13D ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2017-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-17-006131
- Form type
- SC 13D
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Nov 01, 2017
- Reporting period
- Oct 30, 2017
- Description
- Schedule 13D beneficial ownership